---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-008474"
form_type: "8-K"
ticker: "AVR"
cik: "0002011514"
company_name: "Anteris Technologies Global Corp."
filed_at: "2025-03-13T23:59:59+00:00"
generated_at: "2026-05-24T21:40:56.465665+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Anteris Technologies posts FY2024 net loss of $76M; auditor flags going concern doubt

## Summary
- Net loss after tax $76.0M vs $46.8M in 2023; revenue flat at $2.7M.
- Cash balance $70.5M at Dec 31, 2024, after US IPO net proceeds of ~$79.6M.
- Net tangible asset backing per share $1.74 (Dec 2023: $1.04).
- Auditor's report unmodified but includes Emphasis of Matter on going concern.
- IDE submission for DurAVR THV pivotal trial on track for Q1 2025; 86 patients implanted to date.

## SEC filing metadata
- accession: 0001140361-25-008474
- form_type: 8-K
- ticker: AVR
- cik: 0002011514
- company_name: Anteris Technologies Global Corp.
- filed_at: 2025-03-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2011514/000114036125008474/0001140361-25-008474-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2011514/000114036125008474/ef20045173_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-008474
- JSON: https://secwatch.observer/filing/0001140361-25-008474.json
- Plain text: https://secwatch.observer/filing/0001140361-25-008474.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.